Tel:
Email:

News

Advances in siRNA Drug ResearchReview: Drug delivery systems for RNA therapeuticsUpdate on circRNA VaccinesmRNA vaccine expected to prevent diseases caused by ticksVutrisiran, The World's Fourth RNAi Therapy, Is About to Submit A Marketing ApplicationFrom COVID-19 Vaccines to Anti-Cancer Drugs, What Is the Prospect of mRNA Therapy?Alnylam's third RNAi therapy Lumasiran was approved by the European Union for the treatment of primary hyperoxaluria type 1 (PH1)Breaking news: RNAi can significantly inhibit hepatitis B and is expected to become a new treatment for HBVCompeting for the last mile of vaccine research and development, mRNA vaccines become a hot spot for competitionWill the mRNA vaccine become the "savior" of COVID-19?mRNA-1647,the first infectious disease mRNA vaccine to enter the second phase of researchFirst RNAi treatment for inherited rare diseasesbioRxiv.: Scientists Find siRNA drugs that may inhibit SARS-CoV-2Cell Immunity: SARS-CoV-2 vaccines statusOnpattro, The First RNAi-based therapeutic DrugSARS-CoV-2 is undergoing mutations. Does the vaccine still work?Application of LC-MS in the Bioassay of Oligonucleotide DrugsGalNAc Technology for Oligonucleotide Drug DeliveryTherapeutic siRNA: Recent Advances and ProspectsLipids Used in COVID-19 mRNA VaccinesVaccine Adjuvants-CpG Oligonucleotides (CpG ODN)First LNP-mRNA In Vivo Gene Editing Therapy Reports Positive DataFirst mRNA RSV Vaccine Approved for Market ReleaseBridge RNA: Third-Generation Gene Editing Tool on the HorizonGlobal Influenza Vaccine Market Report: Nucleic Acid Vaccines Become MainstreamOpus Genetics Eye Gene Therapy Receives FDA Rare Pediatric Disease DesignationBreakthrough: Novartis' siRNA Therapy Achieves Phase III Success for Atherosclerotic Cardiovascular DiseasemiRNA -The 2024 Nobel Prize in Physiology or Medicine Announcement
* Only for research. Not suitable for any diagnostic or therapeutic use.
Inquiry Basket